Facial Affect Recognition in Myasthenia Gravis

被引:8
作者
Lazaro, Esther [1 ]
Amayra, Imanol [1 ]
Lopez-Paz, Juan Francisco [1 ]
Jometon, Amaia [1 ]
Martin, Natalia [2 ]
Caballero, Patricia [1 ]
De Nicolas, Luis [1 ]
Hoffmann, Holger
Kessler, Henrik
Ruiz, Begona
Martinez, Oscar [1 ]
机构
[1] Univ Deusto, Bilbao, Spain
[2] Univ Valladolid, E-47002 Valladolid, Spain
关键词
myasthenia gravis; facial emotion recognition; NICOTINIC ACETYLCHOLINE-RECEPTORS; EMOTION RECOGNITION; ALZHEIMERS-DISEASE; FEAR RECOGNITION; EXPRESSIONS; IMPAIRMENT; PERCEPTION; MEMORY;
D O I
10.1017/sjp.2013.59
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The assessment of facial expression is an important aspect of a clinical neurological examination, both as an indicator of a mood disorder and as a sign of neurological damage. To date, although studies have been conducted on certain psychosocial aspects of myasthenia, such as quality of life and anxiety, and on neuropsychological aspects such as memory, no studies have directly assessed facial emotion recognition accuracy. The aim of this study was to assess the facial emotion recognition accuracy (fear, surprise, sadness, happiness, anger, and disgust), empathy, and reaction time of patients with myasthenia. Thirty-five patients with myasthenia and 36 healthy controls were tested for their ability to differentiate emotional facial expressions. Participants were matched with respect to age, gender, and education level. Their ability to differentiate emotional facial expressions was evaluated using the computer-based program Feel Test. The data showed that myasthenic patients scored significantly lower (p < 0.05) than healthy controls in the total Feel score, fear, surprise, and higher reaction time. The findings suggest that the ability to recognize facial affect may be reduced in individuals with myasthenia.
引用
收藏
页数:7
相关论文
共 44 条
[31]   Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity [J].
Meriggioli, Matthew N. ;
Sanders, Donald B. .
LANCET NEUROLOGY, 2009, 8 (05) :475-490
[32]   The cholinergic lesion of Alzheimer's disease: Pivotal factor or side show? [J].
Mesulam, M .
LEARNING & MEMORY, 2004, 11 (01) :43-49
[33]   Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses [J].
Miwa, Julie M. ;
Freedman, Robert ;
Lester, Henry A. .
NEURON, 2011, 70 (01) :20-33
[34]  
OSSERMAN K.E., 1958, MYASTHENIA GRAVIS
[35]  
Pérez-Albéniz A, 2003, PSICOTHEMA, V15, P267
[36]   The epidemiology of myasthenia gravis [J].
Phillips, LH .
MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 :407-412
[37]   Processing faces and facial expressions [J].
Posamentier, MT ;
Abdi, H .
NEUROPSYCHOLOGY REVIEW, 2003, 13 (03) :113-143
[38]   Neuropsychological assessment in myasthenia gravis [J].
Sitek, Emilia J. ;
Bilinska, Malgorzata M. ;
Wieczorek, Dariusz ;
Nyka, Walenty M. .
NEUROLOGICAL SCIENCES, 2009, 30 (01) :9-14
[39]   Recognition of facial expressions: Selective impairment of specific emotions in Huntington's disease [J].
Sprengelmeyer, R ;
Young, AW ;
Sprengelmeyer, A ;
Calder, AJ ;
Rowland, D ;
Perrett, D ;
Homberg, V ;
Lange, H .
COGNITIVE NEUROPSYCHOLOGY, 1997, 14 (06) :839-879
[40]   Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology [J].
Thomsen, Morten S. ;
Hansen, Henrik H. ;
Timmerman, Daniel B. ;
Mikkelsen, Jens D. .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (03) :323-343